Efficacy of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis.

Jordan Llerena-Velastegui Melisa Santamaria-Lasso Melany Mejia-Mora Mauricio Santander-Aldean Andrea Granda-Munoz Claudia Hurtado-Alzate Ana Clara Fonseca Souza de Jesus Jurgen Baldelomar-Ortiz

Published in: Cardiology research (2024)

The study highlights the efficacy of carvedilol in improving LVEF in NIDCM patients over ACE inhibitors, recommends beta-blockers as first-line therapy, and advocates further research on ACE inhibitors.

Keyphrases

angiotensin converting enzyme
angiotensin ii
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
stem cells
patient reported outcomes
oxidative stress
smoking cessation
cerebral ischemia